5-arylsulfonyl-imidazo[1′,2′:1,6]pyrido[2,3-b]pyrazine-6-amines and related compounds
US6555538B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 11, 2002 |
| Grant date | Apr 29, 2003 |
| Priority date | — |
| Expiry date | Mar 11, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This application is directed to a compound of Formula I wherein a, X, R1, R2, R3 and R4 are as defined herein, useful in the treatment of respiratory, allergic, rheumatoid, body weight regulation, inflammatory and central nervous system disorders such as asthma, chronic obstructive pulmonary disease, adult respiratory diseases syndrome, shock, fibrosis, pulmonary hypersensitivity, allergic rhinitis, atopic dermatitis, psoriasis, weight control, rheumatoid arthritis, cachexia, Crohn's disease, ulcerative colitis, arthritic conditions and other inflammatory diseases, depression, multi-infarct dementia and AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.